Published in Blood on February 01, 1976
Free light chain synthesis by neoplastic cells in chronic lymphocytic leukaemia and non-Hodgkin's lymphoma. Immunology (1978) 1.39
Expression of immunoglobin G on blood lymphocytes in chronic lymphocytic leukaemia. Clin Exp Immunol (1978) 1.26
Receptors for Helix pomatia A haemagglutinin on leukaemic lymphocytes from patients with chronic lymphocytic leukaemia (CLL). Clin Exp Immunol (1976) 1.14
Morphology of lymphatic cells and of their derived tumours. J Clin Pathol (1978) 0.90
T lymphocytes bearing complement receptors in a patient with chronic lymphocytic leukaemia. Clin Exp Immunol (1977) 0.88
Evidence for a change in the expression of beta2-microglobulin-assoicated membrane structures on leukaemic human cells. Clin Exp Immunol (1978) 0.87
Biosynthesis and characterization of intracellular IgDkappa in a case of CLL. Clin Exp Immunol (1977) 0.86
T-cell and B-cell identification in the diagnosis of lymphoproliferative disease. A review. Am J Pathol (1977) 0.84
Stimulation by CLL cells in mixed lymphocyte culture (MLC). Br J Cancer (1981) 0.75
Structure and biological functions of human IgD. XII. Anti-IgD enhancement of PHA responsiveness in patients with chronic lymphocytic leukaemia. Clin Exp Immunol (1977) 0.75
The human minisatellite consensus at breakpoints of oncogene translocations. Nucleic Acids Res (1990) 1.84
Primary extranodal lymphoma: response to treatment and factors influencing prognosis. Cancer (1978) 1.40
BCL2 oncogene translocation is mediated by a chi-like consensus. J Exp Med (1992) 1.34
Prostatic intraepithelial neoplasia is a risk factor for adenocarcinoma: predictive accuracy in needle biopsies. J Urol (1995) 1.33
Double myeloma. Production of both IgG type lambda and IgA type lambda myeloma proteins by a single plasma cell line. Am J Med (1973) 1.22
Similarities of the light chains and the variable regions of the heavy chains of the IgG2 lambda and IgA1 lambda myeloma proteins from a single patient. J Immunol (1974) 1.04
Bleomycin pulmonary toxicity. Chest (1973) 1.03
Immunoblastic lymphadenopathy. A mixed proliferation of T and B lymphocytes. Am J Clin Pathol (1977) 0.98
The Non-Hodgkin Lymphoma Pathologic Classification Project. Long-term follow-up of 1153 patients with non-Hodgkin lymphomas. Ann Intern Med (1988) 0.93
Phase I evaluation of recombinant interleukin-2 in patients with advanced malignant disease. J Clin Oncol (1986) 0.93
Surface marker and histopathologic correlation with long-term survival in advanced large-cell non-Hodgkin's lymphoma. Cancer (1981) 0.92
Pathways of human B lymphocyte differentiation: a clonal transition between IgM and IgG synthesis in leukemic B lymphocytes. J Immunol (1977) 0.90
Non-Hodgkin lymphoma arising in lower urinary tract. Urology (1985) 0.89
Partial characterization of the shift from IgG to IgA synthesis in the clonal differentiation of human leukemic bone marrow-derived lymphocytes. J Exp Med (1975) 0.86
Nodular non-Hodgkin's lymphoma (NHL): factors influencing prognosis and indications for aggressive treatment. Cancer (1979) 0.86
Treatment of advanced malignant lymphomas with bleomycin. Blood (1972) 0.85
Acquired immunodeficiency syndrome with progressive multifocal leukoencephalopathy and monoclonal B-cell proliferation. Ann Intern Med (1984) 0.84
Hodgkin's disease presenting as "idiopathic" thrombocytopenic purpura. Cancer (1972) 0.84
Multiple myeloma and chronic lymphocytic leukemia in a single individual. Arch Intern Med (1977) 0.83
The binding of IgM aggregates to neoplastic B lymphocytes. II. Fc dependence and implications for a model of B lymphocyte differentiation. J Immunol (1980) 0.82
Infectious mononucleosis in an adult progressing to fatal immunoblastic lymphoma. Ann Intern Med (1982) 0.81
The binding of IgM to B lymphocytes. I. Studies of the binding of aggregated IgM to normal and leukemic human B lymphocytes. Clin Immunol Immunopathol (1980) 0.81
The place of 57Co-bleomycin scanning in the evaluation of tumors. AJR Am J Roentgenol (1977) 0.80
Successful treatment of radiation pericarditis with corticosteroids. Arch Intern Med (1974) 0.78
Clinical and cell surface marker characterization of the early phase of chronic lymphocytic leukemia. Blood (1978) 0.78
Metastatic endotracheal tumor from ovarian carcinoma. Chest (1980) 0.77
Long term survivors with leptomeningeal tumor involvement. Int J Radiat Oncol Biol Phys (1983) 0.77
Malignant granular lymphoproliferation after Epstein-Barr virus infection: partial immunologic reconstitution with interleukin-2. Am J Hematol (1987) 0.77
IgD-Fc receptors on normal and neoplastic human B lymphocytes. Clin Exp Immunol (1982) 0.75
The binding of IgM to B lymphocytes: a comparison of the binding characteristics of IgM aggregates and EAB (IgM) complexes to normal and leukemic B lymphocytes. Proc Soc Exp Biol Med (1983) 0.75
The B cell IgM Fc receptor: further evidence for the B cell origin of "null" chronic lymphocytic leukemia. Blood (1984) 0.75
Surface markers in non-Hodgkin's lymphomas. Hosp Pract (Off Ed) (1983) 0.75
A clinical trial of adriamycin in the malignant lymphomas. Cancer (1974) 0.75
Myeloproliferative disorder with lytic osseous lesions and chromosomal anomalies. Am J Clin Pathol (1974) 0.75
Lymphocyte subsets in primary biliary cirrhosis. Ann Intern Med (1984) 0.75
Letter: Autoimmune thrombocytopenic purpura in Hodgkin's disease. N Engl J Med (1974) 0.75
Cutaneous delayed hypersensitivity, T cell subsets, and IL-2 secretion in patients with peripheral vascular disease. J Clin Lab Immunol (1985) 0.75
The relative roles of gallium-67-citrate scanning and lymphangiography in the current management of malignant lymphoma. Cancer (1977) 0.75
Surface marker identification of small cleaved follicular center cell lymphomas with a highly favorable prognosis. Cancer Res (1982) 0.75
Multiple myeloma with IgG (lambda) and IgA (lambda) serum M-components: immunohistologic studies. J Lab Clin Med (1971) 0.75
Multiple myeloma associated with a basic abnormal protein and unusual plasma cell inclusions. Am J Clin Pathol (1970) 0.75
Prognostic factors for patients with diffuse large cell or immunoblastic non-Hodgkin's lymphomas: experience of the non-Hodgkin's Lymphoma Pathologic Classification Project. Med Pediatr Oncol (1990) 0.75
Clinical usefulness of 67gallium scanning in the malignant lymphomas. Am J Med (1976) 0.75
Immunoglobulin phenotype in CLL. Blood (1984) 0.75
Prognosis of diffuse (non-nodular) non-Hodgkin's lymphoma. Cancer Chemother Rep (1975) 0.75
Myeloma renal disease: evaluation of the role of muramidase (lysozyme). Am J Med Sci (1971) 0.75
Benign pulmonary nodule and small-cell cancer. Ann Intern Med (1982) 0.75
Bleomycin: pulmonary toxicity. Ann Intern Med (1973) 0.75
Oral urea therapy in sickle-cell anemia. A preliminary report. Ann Intern Med (1972) 0.75